Glenmark Pharmaceuticals (GLENMARK.NSE) null Earnings

30SepConfirmed
Jun 17
Sep 17
7.59
9
10.4
11.81

Details

Expected EPS
8.08
Actual EPS
7.59
Surprise EPS
-0.49
Surprise Percent
+6.06%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 7.59 per share for .

0 Comments

Share your thoughts